A more recent study in elderly patients with COPD in whom montelukast 10 mg/day was added documented a decrease in serum levels of LTB4 and interleukin-8 (IL-8) as well as a decrease in the number of outpatient visits and the number and duration of hospitalizations [130]. The gene discussed is CXCL8; the disease is chronic obstructive pulmonary disease.